Editors' Pick

Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.

Khoonsari PEmami, Shevchenko G, Herman S, Remnestål J, Giedraitis V, Brundin RM, Gunnarsson MDegerman, Kilander L, Zetterberg H, Nilsson P, et al.
J Alzheimers Dis. 2019; 67(2):639-651. PMID: 30614806. Abstract